載入...
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy Volunteers
The spleen tyrosine kinase (SYK) regulates immune cell activation in response to engagement of a variety of receptors, making it an intriguing target for the treatment of inflammatory and autoimmune disorders as well as certain B‐cell malignancies. We have previously reported on the discovery and pr...
Na minha lista:
| 發表在: | J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5248591/ https://ncbi.nlm.nih.gov/pubmed/27406873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.794 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|